[脊髓性肌萎缩症康复管理专家共识] - Suppr

Suppr

超能文献

[Expert consensus on rehabilitation management of the spinal muscular atrophy].

出版信息

Zhonghua Er Ke Za Zhi. 2022 Sep 2;60(9):883-887. doi: 10.3760/cma.j.cn112140-20220315-00201.

DOI:10.3760/cma.j.cn112140-20220315-00201

PMID:36038296

Abstract

摘要

相似文献

[Expert consensus on rehabilitation management of the spinal muscular atrophy].

Zhonghua Er Ke Za Zhi. 2022 Sep 2;60(9):883-887. doi: 10.3760/cma.j.cn112140-20220315-00201.

Therapy and rehabilitation of the floppy infant.

R I Med J (1976). 1989 Oct;72(10):367-70.

Spinal muscular atrophy - the dawning of a new era.

Nat Rev Neurol. 2020 Nov;16(11):593-594. doi: 10.1038/s41582-020-00410-7.

Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain.

Pharmacoeconomics. 2022 Apr;40(Suppl 1):3-5. doi: 10.1007/s40273-021-01119-1. Epub 2021 Dec 22.

Treatment of spinal muscular atrophy in European countries: A call to action.

Eur J Neurol. 2022 Nov;29(11):3475-3477. doi: 10.1111/ene.15522. Epub 2022 Aug 22.

Gene therapy for spinal muscular atrophy: hope and caution.

Lancet Neurol. 2021 Apr;20(4):251-252. doi: 10.1016/S1474-4422(21)00071-5. Epub 2021 Mar 17.

Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.

Can J Neurol Sci. 2022 May;49(3):398-401. doi: 10.1017/cjn.2021.125. Epub 2021 Jun 4.

Paradigm shift in the era of disease-modifying therapies for Spinal Muscular Atrophy type 1: respiratory challenges and opportunities.

Sleep Med. 2021 Oct;86:113-115. doi: 10.1016/j.sleep.2021.06.022. Epub 2021 Jun 25.

Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec.

Arch Dis Child. 2023 Oct;108(10):866-867. doi: 10.1136/archdischild-2023-325788. Epub 2023 Aug 8.

Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.

Eur J Paediatr Neurol. 2021 Jan;30:103-104. doi: 10.1016/j.ejpn.2020.12.005. Epub 2020 Dec 14.

引用本文的文献

Rehabilitation for spinal muscular atrophy patients in China: a national cross-sectional study.

Orphanet J Rare Dis. 2024 Jul 25;19(1):279. doi: 10.1186/s13023-024-03291-x.

[Recent research on home rehabilitation and nursing for spinal muscular atrophy].

Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):420-424. doi: 10.7499/j.issn.1008-8830.2310037.

[Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children].

Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):663-671. doi: 10.7499/j.issn.1008-8830.2304036.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Expert consensus on rehabilitation management of the spinal muscular atrophy].

Zhonghua Er Ke Za Zhi. 2022 Sep 2;60(9):883-887. doi: 10.3760/cma.j.cn112140-20220315-00201.

Therapy and rehabilitation of the floppy infant.

R I Med J (1976). 1989 Oct;72(10):367-70.

Spinal muscular atrophy - the dawning of a new era.

Nat Rev Neurol. 2020 Nov;16(11):593-594. doi: 10.1038/s41582-020-00410-7.

Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain.

Pharmacoeconomics. 2022 Apr;40(Suppl 1):3-5. doi: 10.1007/s40273-021-01119-1. Epub 2021 Dec 22.

Treatment of spinal muscular atrophy in European countries: A call to action.

Eur J Neurol. 2022 Nov;29(11):3475-3477. doi: 10.1111/ene.15522. Epub 2022 Aug 22.

Gene therapy for spinal muscular atrophy: hope and caution.

Lancet Neurol. 2021 Apr;20(4):251-252. doi: 10.1016/S1474-4422(21)00071-5. Epub 2021 Mar 17.

Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.

Can J Neurol Sci. 2022 May;49(3):398-401. doi: 10.1017/cjn.2021.125. Epub 2021 Jun 4.

Paradigm shift in the era of disease-modifying therapies for Spinal Muscular Atrophy type 1: respiratory challenges and opportunities.

Sleep Med. 2021 Oct;86:113-115. doi: 10.1016/j.sleep.2021.06.022. Epub 2021 Jun 25.

Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec.

Arch Dis Child. 2023 Oct;108(10):866-867. doi: 10.1136/archdischild-2023-325788. Epub 2023 Aug 8.

Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.

Eur J Paediatr Neurol. 2021 Jan;30:103-104. doi: 10.1016/j.ejpn.2020.12.005. Epub 2020 Dec 14.

引用本文的文献

Rehabilitation for spinal muscular atrophy patients in China: a national cross-sectional study.

Orphanet J Rare Dis. 2024 Jul 25;19(1):279. doi: 10.1186/s13023-024-03291-x.

[Recent research on home rehabilitation and nursing for spinal muscular atrophy].

Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):420-424. doi: 10.7499/j.issn.1008-8830.2310037.

[Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children].

Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):663-671. doi: 10.7499/j.issn.1008-8830.2304036.